Case Study: a global pharmaceutical company improves disease detection and treatment outcomes with Videra Health's AI predictive screener

Global Pharmaceutical Company boosts diagnosis timelines with Videra Health

a global pharmaceutical company faced the challenge of underdiagnosis for a movement disorder, where early detection is critical but limited by the need for specialized clinical expertise. They partnered with Videra Health to leverage a novel AI video-based predictive algorithm to improve screenings and accelerate diagnoses.

Videra Health developed and validated a condition-specific AI algorithm that analyzes video of patients performing simple tasks to identify at-risk individuals. The solution was deployed across clinical and commercial channels, leading to measurable improvements in screening rates, faster diagnosis timelines, and substantially higher prescription rates for appropriate treatments. The scalable framework from Videra Health successfully expanded the pool of patients who could benefit from therapy.

Global Pharmaceutical Company